• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Smiths Medical issues urgent device correction for some CADD infusion pumps

December 12, 2022 By Sean Whooley

Smiths MedicalSmiths Medical today issued an urgent medical device correction letter to inform customers of potential issues with its CADD infusion system.

The company — which ICU Medical acquired in January for $2.35 billion — identified two potential issues with the infusion sets. They relate to the potential lack of delivery or underdelivery and false no disposable attached (NDA) alarms.

According to a news release, lack of delivery or underdelivery may occur due to manufacturing variations. Those variations can potentially cause the green CADD Flow Stop arm to compress. This partially occludes the tubing before clinical use, Smiths Medical said.

If this happens, occlusion potentially fails to resolve when the CADD reservoir or administration set connects to the pump. The pump may not detect the occlusion as well. This could result in underdelivery or non-delivery of medication, even if the pump displays the proper running of the infusion.

Smiths Medical said its second issue relates specifically to CADD-Legacy pumps. The company announced the discontinuation of sales for these effective Dec. 31, 2022.

CADD-Legacy pumps may not detect the attachment of 50 mL and 100 mL CADD medication cassette reservoirs with flow stop to the pump. This could occur even when properly attached. When this happens, the pump initiates the NDA alarm if a double-beep warning isn’t resolved within two minutes.

The user must clear the alarm and resolve the cause of the NDA event before using the pump. The issue does not extend to 250 mL Flow-Stop and non-Flow-Stop CADD medication cassette reservoirs.

Filed Under: Drug-Device Combinations, Featured, Recalls, Regulatory/Compliance Tagged With: ICU Medical, Smiths Medical

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS